Entero Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Entero Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Entero Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $7.78K, a 6.56% increase year-over-year.
  • Entero Therapeutics, Inc. annual Depreciation for 2023 was $29.3K, a 0.01% increase from 2022.
  • Entero Therapeutics, Inc. annual Depreciation for 2022 was $29.3K, a 99% increase from 2021.
  • Entero Therapeutics, Inc. annual Depreciation for 2021 was $14.7K, a 61.1% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $29.3K +$3.00 +0.01% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $29.3K +$14.6K +99% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $14.7K -$23.1K -61.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $37.8K -$25.3K -40.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $63.1K +$1.19K +1.92% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $61.9K +$12.4K +25% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $49.5K +$5.22K +11.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $44.3K +$2.52K +6.03% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $41.8K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.